Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics

Journal of Infectious Diseases

Volumn 199, Issue 1, 2009, Pages 59-65

  Warner, Lee ^a   Ghanem, Khalil G ^c   Newman, Daniel R ^a,b   Macaluso, Maurizio ^a   Sullivan, Patrick S ^b,e   Erbelding, Emily J ^c,d  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BALTIMORE CITY HEALTH DEPARTMENT   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CIRCUMCISION; CONTROLLED STUDY; GENITAL HERPES; GONORRHEA; HEALTH CENTER; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NONSPECIFIC URETHRITIS; PRIORITY JOURNAL; SYPHILIS; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BALTIMORE; CIRCUMCISION, MALE; GONORRHEA; HERPESVIRIDAE INFECTIONS; HETEROSEXUALITY; HIV INFECTIONS; HUMANS; MALE; MEDICAL RECORDS; SYPHILIS; URETHRITIS; YOUNG ADULT;

EID: 58749101526     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/595569     Document Type: Article

References (37)

1. World Health Organization and Joint United Nations Programme on HIV/AIDS (UNAIDS). Male circumcision: global trends and determinants of prevalence, safety, and acceptability. Geneva: World Health Organization, 2007.
2. Donoval BA, Landay AL, Moses S, et al. HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol 2006; 125:386-91.
3. Patterson BK, Landay A, Siegel JN, et al. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 2002; 161:867-73.
4. McCoombe SG, Short RV. Potential HIV-1 target cells in the human penis. AIDS 2006; 20:1491-5.
5. Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 2000; 14:2361-70.
6. Siegfried N, Muller M, Deeks J, et al. HIV and male circumcision - a systematic review with assessment of the quality of studies. Lancet Infect Dis 2005; 5:165-73.
7. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial [see comment]. PLoS Med 2005; 2:e298 (erratum: PLoS Med 2006; 3:e226).
8. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial [see comment]. Lancet 2007; 369:657-66.
9. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial [see comment]. Lancet 2007; 369:643-56.
10. Sullivan PS, Kilmarx PK, Peterman TA, et al. Male circumcision for prevention of HIV transmission: what the new data mean for HIV prevention in the United States. PLoS Med 2007; 4:e233.
11. Telzak EE, Chiasson MA, Bevier PJ, Stoneburner RL, Castro KG, Jaffe HW. HIV-1 seroconversion in patients with and without genital ulcer disease: a prospective study. Ann Intern Med 1993; 119:1181-6.
12. Kassler WJ, Zenilman JM, Erickson B, Fox R, Peterman TA, Hook EW III. Seroconversion in patients attending sexually transmitted disease clinics. AIDS 1994; 8:351-5.
13. Xu F, Markowitz LE, Sternberg MR, Aral SO. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex Transm Dis 2007; 34:479-84.
14. McQuillan GM, Kruszon-Moran D, Kottiri BJ, et al. Prevalence of HIV in the US household population: the National Health and Nutrition Examination Surveys, 1988 to 2002. J Acquir Immune Defic Syndr 2006; 41:651-6.
15. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and dependent areas, 2005. HIV/AIDS Surveillance Report, vol 17. Revised ed. Atlanta: Centers for Disease Control and Prevention, 2007.
16. Warner L, Macaluso M, Austin HD, et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161:765-73.
17. Warner L, Newman DR, Austin HD, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol 2004; 159:242-51.
18. Kleinbaum DG, Klein M. Logistic regression: a self-learning text. 2nd ed. New York: Springer-Verlag, 2002.
19. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
20. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42:121-30.
21. Halloran ME, Longini IM Jr. Using validation sets for outcomes and exposure to infection in vaccine field studies. Am J Epidemiol 2001; 154:391-8.
22. Thomas JC, Stratton S. Sexual transmission. In: Thomas JC, Weber DS, eds. Epidemiologic methods for the study of infectious diseases. New York: Oxford University Press, 2001:267-87.
23. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-9.
24. Niccolai LM, Rowhani-Rahbar A, Jenkins H, Green S, Dunne DW. Condom effectiveness for prevention of Chlamydia trachomatis infection. Sex Transm Infect 2005; 81:323-5.
25. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285:3100-6.
26. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2001:CD003255.
27. Buchbinder SP, Vittinghoff E, Heagerty PJ, et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr 2005; 39:82-9.
28. Mor Z, Kent CK, Kohn RP, Klausner JD. Declining rates in male circumcision amidst increasing evidence of its public health benefit. PLoS ONE 2007; 2:e861.
29. Millett GA, Ding H, Lauby J, et al. Circumcision status and HIV infection among black and Latino men who have sex with men in 3 US cities. J Acquir Immune Defic Syndr 2007; 46:643-50.
30. Kreiss JK, Hopkins SG. The association between circumcision status and human immunodeficiency virus infection among homosexual men. J Infect Dis 1993; 168:1404-8.
31. Grulich AE, Hendry O, Clark E, Kippax S, Kaldor JM. Circumcision and male-to-male sexual transmission of HIV. AIDS 2001; 15:1188-9.
32. Laumann EO, Masi CM, Zuckerman EW. Circumcision in the United States: prevalence, prophylactic effects, and sexual practice. JAMA 1997; 277:1052-7.
33. Wawer MJ, Reynolds SJ, Serwadda D, Kigozi G, Kiwanuka N, Gray RH. Might male circumcision be more protective against HIV in the highly exposed? An immunological hypothesis. AIDS 2005; 19:2181-2.
34. Diseker RA III, Lin LS, Kamb ML, et al. Fleeting foreskins: the misclassification of male circumcision status. Sex Transm Dis 2001; 28:330-5.
35. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-53.
36. Deschamps MM, Pape JW, Hafner A, Johnson WD Jr. Heterosexual transmission of HIV in Haiti. Ann Intern Med 1996; 125:324-30.
37. Centers for Disease Control and Prevention. Consultation on male circumcision for the prevention of HIV infection and other health consequences in the United States. Atlanta: Centers for Disease Control and Prevention, 2007.